Q0HA29 AF NFT

Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 2

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeichtsowbrjdyt5s4f3ub5w3irmac7czn7w7hlypdk6kpinhtb5jrm/metadata.json
IPFS of structure file: 
bafybeif75fymmhcyuonzsguavaeknf2erdnk6ums55b4zac5vfdd54v7iy/AF-Q0HA29-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x41f108fA06D265DE995730b2D626Bd9440871B04
First NFT owner address (bech32): 
genesis1g8cs37sx6fjaax2hxzedvf4aj3qgwxcyl4xtsl
Current NFT ID #266322 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
266322
Accession (UniProt):
Q0HA29
Name::
Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 2
Experimental Method:
Predicted structure
Sequence source:
RATTUS NORVEGICUS

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q0HA29 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q0HA29|NMNA2_RAT Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 2 OS=Rattus norvegicus OX=10116 GN=Nmnat2 PE=2 SV=1 MTETTKTHVILLACGSFNPITKGHIQMFERARDYLHKTGRFIVIGGIVSPVHDSYGKQGLVSSRHRLIMCQLAVQNSDWIRVDPWECYQDTWQTTCSVLEHHRDLMKRVTGCILSNVNTPSMTPVIGQPQHENTQPIYQNSNVPTKPTAAKILGKVGESLGRICCVRPPVERFTFVDENANLGTVMRYEEIELRILLLCGSDLLESFCIPGLWNEADMEVIVGDFGIVVVPRDAADADRIMNHSSILRKYKNNIMVVKDDINHPMSVVSSTKSRLALQHGDGHVVDYLSQPVIDYILKSQLYINASG